Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 湖北亨迪药业股份有限公司于2021年12月22日在深交所创业板上市（股票代码：301211），成立于1995年，现有员工900多人。主要从事医药原料药和制剂产品的研发、生产和销售。注册地和生产基地设于湖北荆门，研发和销售中心设于武汉。公司下设3个子公司：武汉百科药物开发有限公司、武汉亨迪药物开发有限公司、湖北百科医药商贸有限公司，1个分公司：湖北亨迪药业股份有限公司研究院分公司。公司是湖北省博士后医药产业基地、湖北省高新技术企业、华中科技大学同济医学院药学教学基地、湖北省第四批隐性冠军企业、湖北省2020年新冠肺炎抗疫6家重点保供企业之一和全球6大布洛芬原料药生产厂家之一，是全球非甾体抗炎类原料药领先企业。 公司拥有50多个医药原料药和制剂品种，是国内重要的解热镇痛原料药基地、湖北省抗肿瘤特色原料药基地和固体制剂制造基地，产品客户遍及全世界80多个国家和地区。 公司目前拥有8项中国发明专利和1项国外发明专利，共有十几个品种在欧美近20个国家进行了注册，荆门和武汉两个基地多次通过欧美药监局检查认证，是国内同时通过欧美GMP认证检查的为数不多企业之一.经过多年的发展，公司取得了丰富的技术成果，通过自主创新形成自主专利技术，具备行业领先的生产加工工艺，获得了行业和市场的广泛认可。 未来公司将以股票上市为契机，秉持“科学企业，健康人生”经营理念，坚持原料药为主，努力建设成为国内重要的非甾体抗炎类原料药、特色原料药和制剂生产基地，实现原料药与制剂协同发展、进一步探索CDMO的业务布局，立志成为国内领先、国际一流的世界一流制药企业。
Main Business 化学原料药及制剂产品的研发、生产和销售。
Legal Representative 程志刚
Top Executives
董事长：程志刚
董事：肖云华,黄雪强,杨春丽,朱晓兵
独立董事：项光亚,姚克,俞俊利
Top 5 Shareholder
Shareholder name Nature Holding Date
上海勇达圣商务咨询有限公司限售股38.25%31/03/2024
刘天超限售股12.00%31/03/2024
荆门市宁康企业管理中心（有限合伙）限售股5.63%31/03/2024
刘妍超限售股4.50%31/03/2024
刘雯超限售股4.50%31/03/2024
Company Secretary 高健
Solicitors 国浩律师（上海）事务所
Auditors 大信会计师事务所（特殊普通合伙）
Tel No 0724-2223339;0724-2223303
Fax No 0724-2211900
Website www.biocause.com
Email gaojian@biocause.net；chengting@biocause.net
Company Address
Register: 湖北省荆门市荆门高新区·掇刀区杨湾路122号
Office: 湖北省荆门市荆门高新区·掇刀区杨湾路122号
Listing Date 22/12/2021
Shares Capital
Shares Capital: 288,000,000
Total A Share: 288,000,000
Listed A Share: 72,000,000
Non-tradable A Share: 216,000,000
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.610
DPS(RMB)* ¥ 0.480
NBV Per Share(RMB)* ¥ 8.183
Market Capitalization(RMB) 1.120B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.